Skip to content

Propolis in Primary Herpetic Gingivostomatitis

Propolis in Management of Primary Herpetic Gingivostomatitis Measuring the Level of INF-γ in Saliva. Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06778655
Acronym
RCT
Enrollment
60
Registered
2025-01-16
Start date
2024-10-10
Completion date
2025-01-15
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpetic Gingivostomatitis

Brief summary

The purpose of the present study is to investigate the efficacy of 5% propolis gel in the treatment of primary herpetic gingivostomatitis in children and its effect on salivary IFN-γ levels.

Interventions

DIETARY_SUPPLEMENT5% propolis gel

5% propolis gel (prepared according to Joshy et al. 2018) Joshy A, Doggalli N, Patil K, Kulkarni PK. To Evaluate the Efficacy of Topical Propolis in the Management of Symptomatic Oral Lichen Planus: A Randomized Controlled Trial. Contemp Clin Dent. 2018 Jan-Mar;9(1):65-71.

OTHERPlacebo gel

placebo mucoadhesive gel having the same flavor, consistency, and color as the propolis.

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* clinical manifestations suggestive of PHGS * positive culture for HSV-1

Exclusion criteria

* negative culture for HSV-1 * allergic to honey or its products * patients diagnosed with any systemic diseases, immunosuppressed or immunocompromised patients

Design outcomes

Primary

MeasureTime frameDescription
The severity of oral lesionsone weekmild, moderate, severe

Secondary

MeasureTime frameDescription
Painone weekVisual Analogue Scale
measurement of salivary INF-γ levelone weekby ELISA

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026